InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.270
+0.030 (1.34%)
At close: Oct 29, 2025, 4:00 PM EDT
2.270
0.00 (0.00%)
After-hours: Oct 29, 2025, 7:19 PM EDT
InspireMD Revenue
InspireMD had revenue of $1.78M in the quarter ending June 30, 2025, with 2.24% growth. This brings the company's revenue in the last twelve months to $7.07M, up 7.60% year-over-year. In the year 2024, InspireMD had annual revenue of $7.01M with 12.96% growth.
Revenue (ttm)
$7.07M
Revenue Growth
+7.60%
P/S Ratio
15.95
Revenue / Employee
$82,163
Employees
86
Market Cap
94.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.01M | 804.00K | 12.96% |
| Dec 31, 2023 | 6.21M | 1.03M | 20.00% |
| Dec 31, 2022 | 5.17M | 676.00K | 15.04% |
| Dec 31, 2021 | 4.50M | 2.01M | 80.89% |
| Dec 31, 2020 | 2.49M | -1.24M | -33.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
NSPR News
- 8 days ago - InspireMD to Announce Third Quarter 2025 Financial Results - GlobeNewsWire
- 21 days ago - InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - InspireMD Announces the Appointment of Dan Dearen to its Board of Directors - GlobeNewsWire
- 2 months ago - InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - InspireMD, Inc. (NSPR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - InspireMD Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors - GlobeNewsWire
- 3 months ago - InspireMD Announces Combined Financings of $58 Million - GlobeNewsWire